Eidgenossische Technische Hochschule Zurich-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Eidgenossische Technische Hochschule Zurich - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014125
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eidgenossische Technische Hochschule Zurich(ETH Zurich) is an educational university that offers studies in technology and the natural sciences. The university provides scientific education through bachelor programmes and master programmes in the areas of applied geophysics, architecture, biology, agricultural science, agroecosystem science, biomedical engineering, and food science among others. It offers research in various disciplines such as world food system, health, risk research, information processing, cities of the future, climate change, energy, new materials and industrial processes, through several competence centres. ETH Zurich also provides continuing education services and other non degree courses. The university offers technology transfer by providing research projects with industry, licensing opportunities, innovation and setting up companies. ETH Zurich is headquartered in Zurich, Switzerland.

Eidgenossische Technische Hochschule Zurich – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Eidgenossische Technische Hochschule Zurich, Medical Devices Deals, 2011 to YTD 2017 9
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Boehringer Ingelheim Enters Into Research Agreement With ETH Zurich 11
CovalX Enters Into Agreement With Swiss Federal Institute of Technologie For Epitope Mapping 12
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich 13
IBM Enters Into Research Agreement With ETH Zurich And CloudBroker 15
Licensing Agreements 16
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 16
Dualsystems Biotech Enters Into Licensing Agreement With ETH Zurich For Ligand Receptor Capture Technology 17
Swiss Federal Institute Of Technology Enters Into Licensing Agreement With Cell Culture Technologies 18
Eidgenossische Technische Hochschule Zurich – Key Competitors 19
Eidgenossische Technische Hochschule Zurich – Key Employees 20
Eidgenossische Technische Hochschule Zurich – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Key Facts 2
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Eidgenossische Technische Hochschule Zurich, Deals By Therapy Area, 2011 to YTD 2017 8
Eidgenossische Technische Hochschule Zurich, Medical Devices Deals, 2011 to YTD 2017 9
Eidgenossische Technische Hochschule Zurich, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Boehringer Ingelheim Enters Into Research Agreement With ETH Zurich 11
CovalX Enters Into Agreement With Swiss Federal Institute of Technologie For Epitope Mapping 12
Roche Enters Into Joint Venture Agreement With Swiss Federal Institute of Technology, University of Zurich And University Hospital Zurich 13
IBM Enters Into Research Agreement With ETH Zurich And CloudBroker 15
Biognosys Enters into Licensing Agreement with ETH Zurich Foundation 16
Dualsystems Biotech Enters Into Licensing Agreement With ETH Zurich For Ligand Receptor Capture Technology 17
Swiss Federal Institute Of Technology Enters Into Licensing Agreement With Cell Culture Technologies 18
Eidgenossische Technische Hochschule Zurich, Key Competitors 19
Eidgenossische Technische Hochschule Zurich, Key Employees 20
Eidgenossische Technische Hochschule Zurich, Subsidiaries 21
Eidgenossische Technische Hochschule Zurich, Joint Venture 21

★海外企業調査レポート[Eidgenossische Technische Hochschule Zurich-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dian Diagnostics Group Co Ltd (300244):製薬・医療:M&Aディール及び事業提携情報
    Summary Dian Diagnostics Group Co Ltd (Dian Diagnostics) is a medical diagnostic service provider. The company provides forensic authentication services, commercialization of diagnostic products, research and development in medical diagnostics and contract research services. It offers solutions in s …
  • B&M European Value Retail S.A.:企業の戦略・SWOT・財務情報
    B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report Summary B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Storz Medical AG:企業の戦略的SWOT分析
    Storz Medical AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Grupa Azoty SA (ATT):企業の財務・戦略的SWOT分析
    Grupa Azoty SA (ATT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SoftBank Group Corp (9984):企業の財務・戦略的SWOT分析
    SoftBank Group Corp (9984) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • BioRestorative Therapies Inc (BRTX):企業の財務・戦略的SWOT分析
    Summary BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment …
  • Idemitsu Kosan Co., Ltd.:企業の戦略・SWOT・財務情報
    Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Rowan Companies Plc (RDC):石油・ガス:M&Aディール及び事業提携情報
    Summary Rowan Companies Plc (Rowan) is a provider of offshore contract drilling services to the oil and gas industry. It provides drilling services in the in the ultra-deepwater and shallow water jack-up market. Rowan operates self-elevating mobile offshore drilling units and ultra-deepwater drillsh …
  • Putzmeister Holding GmbH:企業の戦略・SWOT・財務分析
    Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Uranium Energy Corp.:企業のM&A・事業提携・投資動向
    Uranium Energy Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Uranium Energy Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • OdontoPrev SA (ODPV3):企業の財務・戦略的SWOT分析
    OdontoPrev SA (ODPV3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fingrid Oyj:企業の戦略的SWOT分析
    Fingrid Oyj - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Summit Midstream Partners LP (SMLP):石油・ガス:M&Aディール及び事業提携情報
    Summary Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gat …
  • Ascena Retail Group Inc (ASNA):企業の財務・戦略的SWOT分析
    Ascena Retail Group Inc (ASNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Dicerna Pharmaceuticals Inc (DRNA):企業の財務・戦略的SWOT分析
    Summary Dicerna Pharmaceuticals Inc (Dicerna) is a biopharmaceutical company that discovers and develops therapeutics for the treatment of rare inherited diseases and cancers. The company’s lead product DCR-PHXC is used for the treatment of primary hyperoxaluria (PH). It offers RNAi technology platf …
  • AngloGold Ashanti Ltd:企業の戦略・SWOT・財務情報
    AngloGold Ashanti Ltd - Strategy, SWOT and Corporate Finance Report Summary AngloGold Ashanti Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Empire District Electric Company:発電所・企業SWOT分析
    The Empire District Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Medigard Ltd (MGZ)-医療機器分野:企業M&A・提携分析
    Summary Medigard Ltd (Medigard), formerly Medisafe Instruments Pty Ltd is a medical device company that designs and develops retractable safety medical devices. The company offers products such as auto-retractable syringe, manual retractable syringe, blood collection device, intravenous valve and fl …
  • Covance Inc:企業の戦略的SWOT分析
    Covance Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Swire Pacific Ltd:戦略・SWOT・企業財務分析
    Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report Summary Swire Pacific Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆